Clough Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,762
Closed -$1.08M 121
2023
Q4
$1.08M Sell
3,762
-518
-12% -$141K 0.12% 103
2023
Q3
$1.15M Sell
4,280
-11,800
-73% -$2.94M 0.12% 117
2023
Q2
$3.57M Buy
16,080
+12,680
+373% +$2.94M 0.36% 82
2023
Q1
$822K Hold
3,400
0.09% 136
2022
Q4
$893K Buy
+3,400
New +$911K 0.09% 131
2021
Q1
Sell
-31,932
Closed -$7.34M 148
2020
Q4
$7.34M Sell
31,932
-83,185
-72% -$19.2M 0.52% 65
2020
Q3
$29.3M Buy
115,117
+56,660
+97% +$14M 2.1% 12
2020
Q2
$13.8M Sell
58,457
-9,500
-14% -$2.17M 1.35% 20
2020
Q1
$13.8M Buy
67,957
+14,410
+27% +$3.15M 1.37% 25
2019
Q4
$12.9M Buy
53,547
+6,452
+14% +$1.42M 1.1% 34
2019
Q3
$9.11M Buy
47,095
+15,810
+51% +$3.03M 0.75% 40
2019
Q2
$5.76M Sell
31,285
-33,230
-52% -$5.95M 0.57% 63
2019
Q1
$12.3M Buy
64,515
+5,770
+10% +$1.1M 1.07% 30
2018
Q4
$11.4M Sell
58,745
-5,155
-8% -$1.01M 1.34% 20
2018
Q3
$13.2M Sell
63,900
-2,900
-4% -$572K 1.25% 24
2018
Q2
$12.3M Buy
66,800
+13,560
+25% +$2.4M 1.1% 29
2018
Q1
$9.08M Buy
+53,240
New +$9.77M 0.87% 43

Other funds holding AMGN

Clough Capital Partners's AMGN Position: Q1 2024 in Review

Clough Capital Partners sold out of Amgen (AMGN) in Q1 2024, closing a stake of 3,762 shares — an estimated $1.08M sold.

Clough Capital Partners first reported a position in AMGN in Q1 2018 and held it in 17 quarters. The position peaked at $29.3M in Q3 2020. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Clough Capital Partners reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Clough Capital Partners sold 3,762 Amgen shares in Q1 2024, an estimated $1.08M.
  • Clough Capital Partners first reported a position in Amgen in Q1 2018 and held it in 17 quarters.
  • Clough Capital Partners's Amgen position peaked at $29.3M in Q3 2020.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Clough Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.